Back to Results
First PageMeta Content
Headaches / Rhinology / Sinusitis / Otolaryngology / Sinus / Medicine / Health / General practice


Media Contact: Nicole Osmer[removed]removed] Intersect ENT Announces Positive Data from Pivotal Study of Propel Implant, Showing Significantly Improved Outcomes For Sinus Surgery
Add to Reading List

Document Date: 2014-04-17 10:11:17

Open Document

File Size: 172,27 KB

Share Result on Facebook

City

San Francisco / Palo Alto / /

Company

U.S. Venture Partners / Intersect ENT Inc. / Medtronic / Rhinology / /

Country

United States / /

/

Event

FDA Phase / /

Facility

Elwell Court / Eastern Virginia Medical Center / University of Texas Southwestern Medical Center / /

IndustryTerm

treatment solutions / /

MedicalCondition

scar / headache / chronic / sinusitis / inflammation / chronic sinusitis / recurrent inflammation / facial pain / /

MedicalTreatment

sinus surgery / Neck Surgery / surgery / Head and Neck Surgery / /

Organization

American Academy of Otolaryngology / U.S. Food and Drug Administration / University of Texas Southwestern Medical Center in Dallas / /

Person

Bradley F. Marple / Lisa Earnhardt / Joseph Han / Maurice Cottle / Nicole Osmer / /

/

Position

professor and vice chairman of the Department / director / president and CEO / associate professor at the Eastern Virginia Medical Center / physician / Otolaryngology-Head / surgeon / Head / /

Product

mometasone furoate / Propel Implant / /

ProvinceOrState

Virginia / California / /

Region

Eastern Virginia / /

Technology

drug delivery / /

URL

www.intersectENT.com / /

SocialTag